Delay in AIDS drug use in South Africa costly
NEW YORK (Reuters Health) - Researchers from Harvard School of Public Health in Boston estimate that between 2000 and 2005 more than 330,000 lives were lost because a “feasible and timely” AIDS drug treatment program was not implemented in South Africa.
By not implementing a mother-to-child transmission HIV prevention program during the same 5-year period, an estimated 35,000 infants were born with HIV.
Dr. Pride Chigwedere and colleagues describe their analyses that generated these estimates in a Perspectives article published online in the Journal of Acquired Immune Deficiency Syndromes.
By way of background, at the peak of the South Africa AIDS epidemic, they explain, “the government, going against consensus scientific opinion, argued that HIV was not the cause of AIDS and that antiretroviral drugs were not useful for patients and declined to accept freely donated nevirapine (an AIDS drug) and grants from the Global Fund.”
To estimate lost benefits due to these decisions, the investigators compared the actual number of South Africans who received drugs for treatment of HIV infection or for prevention of mother-to-child HIV transmission between 2000 and 2005 with what was reasonably feasible in the country during that period. They then multiplied the differences by the average “life-years” conferred by antiretroviral therapy for African patients with AIDS or the efficacy of antiretroviral treatment in preventing mother-to-child transmission.
For comparison, the researchers used data from Botswana and Namibia, neighboring countries facing a similar burden of HIV/AIDS and with similar resources per capita. In contrast to South Africa, Botswana and Namibia began a program for the prevention of mother-to-child transmission in 1999 and a national AIDS treatment program in 2001.
The investigators estimate that the total lost benefits of not using antiretroviral drugs between 2000 and 2005 amount to at least 3.8 million “person-years.”
“Access to appropriate public health practice is often determined by a small number of political leaders,” they note in their report.
“In the case of South Africa, many lives were lost because of a failure to accept the use of available antiretrovirals to prevent and treat HIV/AIDS in a timely manner,” they conclude.
SOURCE: Journal of Acquired Immune Deficiency Syndromes, 2008.
--------------------------------------------------------------------------------------------Related Posts:
By Michael Kahn LONDON (Reuters) - Near-universal HIV tests and immediate drug treatment for people who test positive would almost eliminate transmission of the deadly virus within a decade, a computer model showed on Wednesday. Doing this would cost more initially but then save money down the road because there would be fewer HIV-infected people to treat,
Full Post: Universal HIV tests would have big impact: study
--------------------------------------------------------------------------------------------
By Louis Charbonneau UNITED NATIONS (Reuters) - The United Nations on Monday urged countries across the world to expand screening of newborn infants exposed to the virus that causes AIDS, saying it could save the lives of countless children. “Without appropriate treatment, half of children with HIV will die from an HIV-related cause by their second birthday,”
Full Post: More HIV testing can save babies’ lives: U.N. report
--------------------------------------------------------------------------------------------
BEIJING (Reuters) - The number of gay men in China who are HIV positive has risen sharply in the last three years, according to a survey of Chinese cities conducted by the Ministry of Health. Men with HIV make up 4.9 percent of the gay population, up from 0.4 percent in 2005, the Xinhua news agency
Full Post: China sees sharp rise in HIV-positive gay men
--------------------------------------------------------------------------------------------
By Andrew Quinn WASHINGTON (Reuters) - A global AIDS vaccine conference this week will seek fresh strategies against the HIV virus, with experts weighing the value of basic laboratory research against large-scale human clinical trials after a string of disappointments. Approaches focusing on “neutralizing antibodies” that would allow the human immune system to block infection completely, are
Full Post: AIDS vaccine focus shifts after disappointments
--------------------------------------------------------------------------------------------
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - Three studies published on Wednesday add to evidence that circumcision can protect men from the deadly AIDS virus and the sexually transmitted virus that causes cervical cancer. The reports in the Journal of Infectious Diseases are likely to add to the debate over whether men — and
Full Post: Male circumcision lowers cervical cancer risk: study